ArticleBMC complementary medicine and therapies2025
A survey on the current status of Korean Medicine practices for asthma among Korean Medicine doctors.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAsthma is a chronic respiratory disease affecting millions of people worldwide, with a growing prevalence in South Korea. Korean medicine (KM), which includes herbal medicine, acupuncture, moxibustion, cupping, and other holistic therapies, is widely used for asthma treatment in South Korea. However, data on the clinical practices of Korean medicine doctors (KMDs) are limited. This study aimed to assess the current status of KM practices in treating asthma.
methodsA clinical practice survey was conducted from 22 July to 5 August 2024, targeting all licenced KMDs. A total of 27,662 KMDs were invited and 402 completed the survey. The questionnaire collected data on demographics, diagnostic and treatment practices and challenges in the management of asthma. Descriptive statistics were used to summarise the findings.
resultsHerbal medicine (97.76%) and acupuncture (68.41%) were the primary treatments for asthma, with high patient satisfaction (93.78% for herbal medicine). The most prescribed herbal formulas were Maekmundong-tang (43.03%) and Cheongsangboha-tang (41.29%). Most KMDs treated mild asthma (67.71%) and reported high levels of integration with Western medicine (WM), with 38.56% of KMDs indicating that 76 - 100% of their patients used Western medications concurrently. Key challenges included financial barriers (64.43%) and a need for better access to diagnostic tools and standardised treatment protocols.
conclusionThis clinical practice survey provides valuable information on the clinical practices of KMDs in asthma care, underscoring the significant role of herbal medicine and acupuncture. The findings clarify treatment approaches and patient groups suited to KM, offering a foundation for future clinical trials, clinical pathway (CP) development and integration with WM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.